Sotair for Manual Resuscitation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to test different methods of manual ventilation, the process of assisting breathing with a hand-held bag. The research will evaluate the effectiveness of three setups in scenarios simulating various lung conditions. Participants will assess a standard resuscitator bag, a flow-limiting bag, and a flow rate limiting device combined with a standard bag. Ideal participants are adults with basic life support certification who can commit to a 10-hour session. As an unphased trial, this study allows participants to contribute to innovative research that could enhance emergency medical care techniques.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this device is safe for manual resuscitation?
Research has shown that the Sotair device, when used with manual resuscitators, maintains safe air flow rates. It controls the air entering the lungs, preventing issues like over-inflation. Studies indicate it effectively limits inhaled air, reducing high lung pressure.
The FDA has approved the device for use with manual resuscitators in patients unable to breathe independently. This approval confirms its safety in specific situations.
No specific data on negative effects appear in the sources, but the Sotair device's approval for similar uses offers some reassurance about its safety.12345Why are researchers excited about this trial?
Researchers are excited about the Sotair device because it could enhance manual resuscitation techniques. Unlike traditional methods using just an Ambu bag, the Sotair device is integrated into the process to potentially improve ventilation efficiency, particularly with patients who have low lung compliance. This innovation could lead to better patient outcomes by offering more consistent ventilation support. By investigating the performance of this new device in different lung compliance scenarios, researchers hope to discover improved strategies for manual ventilation, ultimately benefiting emergency and critical care protocols.
What evidence suggests that this trial's treatments could be effective?
Research has shown that the Sotair device, which participants in this trial may receive, could improve manual ventilation. Studies indicate it helps maintain important measures like peak airway pressure and tidal volume (the amount of air moving in and out of the lungs) near ideal levels. This improvement could make manual ventilation safer and more effective, especially compared to using a bag-valve-mask (BVM) alone. The FDA has approved the device for limiting airflow, which helps prevent excessive pressure that could harm the lungs. These features suggest that Sotair could become a new standard in emergency ventilation care.678910
Who Is on the Research Team?
Mark Brady, MD
Principal Investigator
Brown Physicians, Inc.
Are You a Good Fit for This Trial?
This trial is for individuals who are at least 18 years old with a current basic life support (BLS) certification. Participants must be available to complete the full 10-hour protocol. Those with medical or respiratory therapy school training, or who cannot commit to the full duration, are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Simulation
Participants undergo simulated lung scenarios using various manual resuscitator bags and devices
Follow-up
Participants are monitored for safety and effectiveness after simulation
What Are the Treatments Tested in This Trial?
Interventions
- Prolonged Manual Ventilation Simulation
Find a Clinic Near You
Who Is Running the Clinical Trial?
SafeBVM
Lead Sponsor
United States Department of Defense
Collaborator